| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.03. | Brain+ A/S: Bankruptcy order issued for BRAIN+ A/S | 168 | GlobeNewswire (Europe) | INSIDE INFORMATION
COMPANY ANNOUNCEMENT No. 2026-10
BRAIN+ A/S - Other information disclosed according to the rules of the Exchange
Bankruptcy order issued for BRAIN+ A/S
Copenhagen, Denmark, 23 March... ► Artikel lesen | |
| 19.03. | Brain+ A/S: BRAIN+ A/S to file for bankruptcy - 19 March 2026 | 239 | GlobeNewswire (Europe) | INSIDE INFORMATION
COMPANY ANNOUNCEMENT No. 2026-9
BRAIN+ A/S - Other information disclosed according to the rules of the Exchange
BRAIN+ A/S to file for bankruptcy - 19 March 2026
Copenhagen, Denmark... ► Artikel lesen | |
| 19.03. | Brain+ A/S - suspension | 214 | GlobeNewswire | Nasdaq Copenhagen has suspended trading in Brain+ A/S until further notice. Awaiting information from the company.
Further information:
Issuer Surveillance +45... ► Artikel lesen | |
| BRAIN+ A/S Aktie jetzt für 0€ handeln | |||||
| 04.02. | Brain+ A/S: Update on in-court restructuring proceedings - 4 February 2026 | 294 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2026-5
BRAIN+ A/S - Investor News
Copenhagen, Denmark, 4 February 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Copenhagen, Denmark, 4 February 2026 Brain+ A/S (the "Company")... ► Artikel lesen | |
| 20.01. | Brain+ A/S: Notice of in-court restructuring proceedings of BRAIN+ A/S | 238 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2026-2
Brain+ A/S - Inside information
Copenhagen, Denmark, 20 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Copenhagen, Denmark, 20 January 2026 - BRAIN+ A/S (the "Company")... ► Artikel lesen | |
| 20.01. | Brain+ A/S: Brain+ is seeking restructuring proceedings | 276 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT NO. 2026-1
Copenhagen, Denmark, 20 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
As previously announced on 19 November 2025, Brain+ A/S has been exploring various options... ► Artikel lesen | |
| 08.01. | Brain+ A/S: Brain+ Investor Update - December 2025 | 234 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 8 January 2026, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued international expansion alongside strengthened traction in its home market of Denmark... ► Artikel lesen | |
| 04.12.25 | Brain+ A/S: Brain+ Investor Update - November | 224 | GlobeNewswire (Europe) | NEWS RELEASE
Brain+ Investor Update - November
Copenhagen, Denmark, 4 December 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued commercial traction, national research recognition... ► Artikel lesen | |
| 19.11.25 | Brain+ A/S: Brain+ A/S updates its financial guidance for 2025 | 241 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2025-19
Copenhagen, Denmark, 19 November 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") updates its financial guidance for 2025 to reflect... ► Artikel lesen | |
| 06.11.25 | Brain+ A/S: Brain+ investor update - October | 209 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 6 November 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued commercial traction and operational expansion in its October investor update,... ► Artikel lesen | |
| 06.10.25 | Brain+ A/S: Brain+ appoints new Chief Financial Officer | 240 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-18Copenhagen, Denmark, 6 October 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has appointed Otto Rasmussen, an experienced financial... ► Artikel lesen | |
| 24.09.25 | Brain+ A/S: Brain+ launches first Ayla NHS pilot with one of the UK's largest primary care practices | 220 | GlobeNewswire (Europe) | NEWS RELEASECopenhagen, Denmark, 24 September 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has signed an agreement with a large primary care practice in the South... ► Artikel lesen | |
| 16.09.25 | Brain+ A/S: Brain+ signs agreement with Agincare Homes - the fourth UK care home group to deploy effective dementia therapy with Ayla | 327 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, September 16, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has signed an agreement with Agincare Homes Holdings Ltd, UK ("Agincare")... ► Artikel lesen | |
| 15.09.25 | Brain+ A/S: The Chief Financial Officer to transition, replacement search has been initiated | 257 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-17
Copenhagen, Denmark, September 15, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") announces that its Chief Financial Officer... ► Artikel lesen | |
| 02.09.25 | Brain+ A/S: Brain+ expands its agreement with Southcare Homes Group to deploy Ayla across the group | 361 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 2 September 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has signed an expanded contract with Southcare Homes Group ("Southcare")... ► Artikel lesen | |
| 28.08.25 | Brain+ A/S: Brain+ publishes Half Year Report for 2025 | 328 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-16Copenhagen, Denmark, August 28, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
In H1 2025, Brain+ A/S ("Brain+" or "the Company") realized a net result of DKK -8.0... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADVANCED BIOMED | 9,000 | +1,12 % | Morning Market Movers: Baiya International Group, Globavend, Advanced Biomed, Sadot Group See Big Swings | CANBERA (dpa-AFX) - At 7:25 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 70,54 | +0,06 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 | NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE: GTLS)... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 26,260 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,340 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,090 | -0,05 % | Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now | ||
| FRESENIUS MEDICAL CARE | 42,770 | +1,11 % | FMC: Analysten sehen Abwärtspotenzial | Am 4. August wird Fresenius Medical Care, kurz FMC, die Zahlen zum zweiten Quartal vorstellen. Die Analysten der Deutschen Bank rechnen mit einem organischen Umsatzplus von 3 Prozent. Deutlicher soll... ► Artikel lesen | |
| FRESENIUS | 43,320 | +1,48 % | Fresenius: Hoffnungen auf Prognoseanhebung und Kurssprung | Fresenius steht möglicherweise vor einer Anhebung seiner Jahresprognose, nachdem Analysten ein starkes zweites Quartal erwarten. Die Deutsche Bank sieht weiteres Kurspotenzial und hält trotz bereits... ► Artikel lesen | |
| BILLIONTOONE | 125,20 | +0,05 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,600 | -1,65 % | ANALYSE-FLASH: UBS belässt Siemens Healthineers auf 'Neutral' - Ziel 38 Euro | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 38 Euro auf "Neutral" belassen. In der Radiotherapie heiße es nicht mehr nur... ► Artikel lesen | |
| GENEDX | 60,73 | +0,13 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| AVEANNA HEALTHCARE | 9,690 | 0,00 % | Aveanna Healthcare (AVAH): Best Future Stocks to Buy Under $10 | ||
| CARL ZEISS MEDITEC | 27,800 | -3,27 % | Carl Zeiss Meditec, Jost Werke: frische Shortpositionen - bei Deutz wie Symrise Fonds auf Rückzug | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert, unterliegt Transparenzpflichten gemäß EU-Leerverkaufsverordnung. Ab einer Netto-Leerverkaufsposition von 0,5 Prozent des ausgegebenen Aktienkapitals... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,220 | 0,00 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 31,750 | -0,06 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| HEARTFLOW | 24,540 | -0,08 % | Stifel reiterates HeartFlow stock rating after cardiology meeting |